New inhaled therapy aims to stop lung transplant failure
Disease control
Recruiting now
This study tests an inhaled drug called ARINA-1 in 100 people who have had a double lung transplant and show early signs of lung decline. The goal is to see if adding ARINA-1 to standard care can prevent or slow down a serious condition called bronchiolitis obliterans syndrome (B…
Phase: PHASE3 • Sponsor: Renovion, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC